A notice indicates that the Wisconsin Advisory Committee to the U.S. Commission on Civil Rights will hold virtual business meetings via Zoom on Thursday, November 19, 2026, and Thursday, December 17, 2026, in accordance…
A notice indicates that the Tennessee Advisory Committee to the U.S. Commission on Civil Rights plans to hold virtual business meetings via Zoom on Monday, December 7, 2026, and Monday, January 11, 2027, each from 3:00…
A notice from the Department of War indicates that a meeting of the President's Military Spouse Commission's Federal Advisory Committee is planned, though specific date, agenda, and participants are not detailed in the…
A notice indicates that the New York Advisory Committee, operating under the U.S. Commission on Civil Rights and the Federal Advisory Committee Act, will hold a public Zoom briefing to continue work on its project…
The Georgia Advisory Committee, operating under the U.S. Commission on Civil Rights and the Federal Advisory Committee Act, announced that it will hold public meetings via Zoom. The first two meetings are intended to…
A notice indicates that the Virginia Advisory Committee of the U.S. Commission on Civil Rights will hold public meetings via Zoom, aiming to hear expert testimony and continue briefing and planning activities. Specific…
A notice issued under the U.S. Commission on Civil Rights regulations and the Federal Advisory Committee Act announces that the Oklahoma Advisory Committee will hold virtual business/briefing meetings via ZoomGov on…
A notice announces that the U.S. Integrated Ocean Observing System (IOOS) Advisory Committee will hold a virtual meeting that is open to the public, offering participants the chance to provide oral and written comments.
A notice has been issued stating that the Rail Energy Transportation Advisory Committee (RETAC) will hold a meeting in accordance with the Federal Advisory Committee Act. Specific agenda items, date, time, and location…
The U.S. Food and Drug Administration has stated that the Commissioner of Food and Drugs determined it is in the public interest to extend the Dermatologic and Ophthalmic Drugs Advisory Committee’s charter for an…